PMID- 26456820 OWN - NLM STAT- MEDLINE DCOM- 20160804 LR - 20211203 IS - 2211-1247 (Electronic) VI - 13 IP - 3 DP - 2015 Oct 20 TI - Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins. PG - 524-532 LID - S2211-1247(15)01025-6 [pii] LID - 10.1016/j.celrep.2015.09.014 [doi] AB - As the key effector in the Hippo pathway, YAP was identified as an oncoprotein whose expression is elevated in various human cancers. However, the development of potentially therapeutic compounds targeting YAP has been slow and limited. Here, we find that tankyrase inhibitors suppress YAP activity. This effect is mediated by anigomotin (AMOT) family proteins. Tankyrases associate with AMOT family proteins and promote their degradation through E3 ligase RNF146. By antagonizing tankyrase activity, tankyrase inhibitors stabilize AMOT family proteins, thereby suppressing YAP oncogenic functions. Together, our studies not only demonstrate the tankyrase-RNF146-AMOT axis as an upstream pathway regulating YAP but also reveal a therapeutic opportunity in targeting YAP for cancer treatment. CI - Copyright (c) 2015 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Wang, Wenqi AU - Wang W AD - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: wwang5@mdanderson.org. FAU - Li, Nan AU - Li N AD - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. FAU - Li, Xu AU - Li X AD - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. FAU - Tran, My Kim AU - Tran MK AD - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. FAU - Han, Xin AU - Han X AD - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. FAU - Chen, Junjie AU - Chen J AD - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: jchen8@mdanderson.org. LA - eng GR - P30 CA016672/CA/NCI NIH HHS/United States GR - R01 CA092312/CA/NCI NIH HHS/United States GR - R01 CA100109/CA/NCI NIH HHS/United States GR - CA016672/CA/NCI NIH HHS/United States GR - R01 CA089239/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20151008 PL - United States TA - Cell Rep JT - Cell reports JID - 101573691 RN - 0 (AMOT protein, human) RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Angiomotins) RN - 0 (Enzyme Inhibitors) RN - 0 (G007-LK) RN - 0 (Heterocyclic Compounds, 3-Ring) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Membrane Proteins) RN - 0 (Microfilament Proteins) RN - 0 (Phosphoproteins) RN - 0 (Sulfones) RN - 0 (Transcription Factors) RN - 0 (Triazoles) RN - 0 (XAV939) RN - 0 (YAP-Signaling Proteins) RN - 0 (YAP1 protein, human) RN - EC 2.3.2.27 (RNF146 protein, human) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.4.2.30 (Tankyrases) SB - IM MH - Adaptor Proteins, Signal Transducing/*metabolism MH - Angiomotins MH - Enzyme Inhibitors/*pharmacology MH - HEK293 Cells MH - Heterocyclic Compounds, 3-Ring/pharmacology MH - Humans MH - Intercellular Signaling Peptides and Proteins/*metabolism MH - MCF-7 Cells MH - Membrane Proteins/*metabolism MH - Microfilament Proteins MH - Phosphoproteins/*metabolism MH - Protein Binding MH - Protein Stability MH - *Proteolysis MH - Sulfones/pharmacology MH - Tankyrases/*antagonists & inhibitors/metabolism MH - Transcription Factors MH - Triazoles/pharmacology MH - Ubiquitin-Protein Ligases/metabolism MH - YAP-Signaling Proteins PMC - PMC4618173 MID - NIHMS722396 EDAT- 2015/10/13 06:00 MHDA- 2016/08/05 06:00 PMCR- 2015/10/24 CRDT- 2015/10/13 06:00 PHST- 2015/05/25 00:00 [received] PHST- 2015/07/20 00:00 [revised] PHST- 2015/09/03 00:00 [accepted] PHST- 2015/10/13 06:00 [entrez] PHST- 2015/10/13 06:00 [pubmed] PHST- 2016/08/05 06:00 [medline] PHST- 2015/10/24 00:00 [pmc-release] AID - S2211-1247(15)01025-6 [pii] AID - 10.1016/j.celrep.2015.09.014 [doi] PST - ppublish SO - Cell Rep. 2015 Oct 20;13(3):524-532. doi: 10.1016/j.celrep.2015.09.014. Epub 2015 Oct 8.